<DOC>
	<DOCNO>NCT00329082</DOCNO>
	<brief_summary>To study safety LY2062430 patient mild-to-moderate Alzheimer 's disease healthy volunteer .</brief_summary>
	<brief_title>Effects LY2062430 Subjects With Mild-to-Moderate Alzheimer 's Disease Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>At least 50 year age diagnose mild moderate Alzheimer 's disease healthy volunteer fluent read speak English AD patient must reliable study partner frequent contact patient comply protocol requirement AD patient receive AChEIs memantine least 4 month stable therapy least 2 month prior start study drug Have history serious infectious disease affect brain , head trauma , cancer , drug alcohol abuse past 5 year Have serious uncontrolled health problem laboratory test Multiple severe drug allergy Prior participation active immunization study</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>